Diopsys Inks $14M Deal Resolving Vision Testing FCA Claims

By Hailey Konnath · March 27, 2025, 10:58 PM EDT

Medical device maker Diopsys Inc. has agreed to pay up to $14.25 million to put to rest allegations it violated the False Claims Act by submitting false Medicare and Medicaid claims...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login